APA (7th ed.) Citation

Chen, L., Chiou, W., Lin, H., Lee, M., Lo, Y., Huang, L., . . . Hung, S. (2019). Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): A randomized controlled trial. BMC.

Chicago Style (17th ed.) Citation

Chen, Liang-Cheng, et al. Comparing Stereotactic Ablative Radiotherapy (SABR) Versus Re-trans-catheter Arterial Chemoembolization (re-TACE) for Hepatocellular Carcinoma Patients Who Had Incomplete Response After Initial TACE (TASABR): A Randomized Controlled Trial. BMC, 2019.

MLA (9th ed.) Citation

Chen, Liang-Cheng, et al. Comparing Stereotactic Ablative Radiotherapy (SABR) Versus Re-trans-catheter Arterial Chemoembolization (re-TACE) for Hepatocellular Carcinoma Patients Who Had Incomplete Response After Initial TACE (TASABR): A Randomized Controlled Trial. BMC, 2019.